Seth Klarman
Baupost Group
Seth Klarman FINCH THERAPEUTICS GROUP INC stake
total: 272
Baupost Group FNCHQ trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 1
- Reduced:
- 4
- Held since:
- 2021 Q1
- Held for:
- 12 quarters
- Latest activity:
- 2024 Q1
According to 2026 Q2 report, Seth Klarman doesn't hold any FINCH THERAPEUTICS GROUP INC (FNCHQ) shares. To date, the estimated cost basis is nearly $261.7 for "buy" trades and estimated average "sell" price is $14.89. Baupost Group first purchased FNCHQ in 2021 Q1, initially acquiring 40,272 shares. Since the initial investment in FINCH THERAPEUTICS GROUP INC (FNCHQ), Baupost Group has made 6 more transactions.
When did Seth Klarman sell FINCH THERAPEUTICS GROUP INC (FNCHQ)?
Seth Klarman sold off the entire FINCH THERAPEUTICS GROUP INC (FNCHQ) position in 2024 Q1.
When did Seth Klarman buy FINCH THERAPEUTICS GROUP INC (FNCHQ)?
Seth Klarman first invested in FINCH THERAPEUTICS GROUP INC (FNCHQ) in 2021 Q1 at the reported quarter-end price of $468.56 per share.
What's the cost basis of Baupost Group's FNCHQ stake?
The estimated cost basis for FINCH THERAPEUTICS GROUP INC (FNCHQ) stake is around $261.70 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $261.70
- Weighted AVG sell price:
- $14.89
Seth Klarman's historical trades in FINCH THERAPEUTICS GROUP INC
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2024 Q1
|
0.00%
|
0
|
$3.61
|
|
-100% (-67,296)
|
-0.01%
|
|
2023 Q2
|
0.01%
|
67,296
|
$8.53
|
$574,000
|
-0.01% (-4.27)
|
0%
|
|
2023 Q1
|
0.01%
|
67,300.27
|
$11.78
|
$793,000
|
+98.13% (+33,333.34)
|
+0.01%
|
|
2022 Q4
|
0.01%
|
33,966.93
|
$14.40
|
$489,000
|
-9.27% (-3,470)
|
-0%
|
|
2022 Q1
|
0.06%
|
37,436.93
|
$150.89
|
$5,649,000
|
-0.81% (-304.84)
|
-0%
|
|
2021 Q4
|
0.11%
|
37,741.77
|
$299.11
|
$11,289,000
|
-6.28% (-2,530.2)
|
-0.01%
|
|
2021 Q1
|
0.15%
|
40,271.97
|
$468.56
|
$18,870,000
|
new
|
+0.15%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.